即时血液诊断市场：分散化检测推动医疗诊断变革
| 2025年市场规模 | 29.01亿美元 |
| 2030年预测 | 42.63亿美元 |
| 2035年预测 | 59.76亿美元 |
| 主要驱动因素 | 老龄化人口、分散诊断、技术进步 |
市场概况
准确和及时的血液检测在现代医疗保健中变得越来越关键，尤其是随着诊疗交付向更接近患者的方向转移。医院、诊所和诊断中心更加重视更快的周转时间和分散检测能力。这种转变正在加强即时血液学诊断市场的相关性。
Accurate and timely blood testing is becoming increasingly critical in modern healthcare, especially as care delivery shifts closer to patients. Hospitals, clinics, and diagnostic centers are placing greater emphasis on faster turnaround times and decentralized testing capabilities.
即时血液学诊断市场在2025年达到29.01亿美元，反映了自2020年以来以8.3%的复合年增长率稳步扩张。市场预计到2030年将以8.0%的复合年增长率增长到42.63亿美元，随后到2035年以7.0%的复合年增长率进一步增长到59.76亿美元。
The point of care hematology diagnostics market reached $2,900.5 million in 2025, reflecting steady expansion at a CAGR of 8.3% since 2020. The market is expected to grow to $4,262.6 million by 2030 at a CAGR of 8.0%.
细分市场分析
按类型划分，全血细胞计数检测继续领先，因其在常规诊断中的重要作用。血红蛋白检测正成为增长最快的细分市场，因其在检测贫血方面的重要性而受到推动。按处方模式划分，处方药产品因临床可靠性而占主导地位，而非处方药选项在寻求便捷检测解决方案的消费者中越来越受欢迎。
By type, complete blood count testing continues to lead due to its essential role in routine diagnostics. Hemoglobin testing is emerging as the fastest-growing segment, driven by its importance in detecting anemia. By mode of prescription, prescription-based products dominate due to clinical reliability.
按最终用户划分，医院仍然是主要采用者，因为患者量大且需要即时诊断。同时，随着对专业和分散检测需求的增加，诊断中心正在快速扩展。诊断中心正在成为一个重要的增长领域，得到了快速和便捷检测患者需求上升的支持。
By end user, hospitals remain the primary adopters because of high patient volumes and immediate diagnostic needs. Meanwhile, diagnostic centers are expanding rapidly as demand for specialized and decentralized testing increases.
地区分布与技术趋势
北美在即时血液学诊断市场中占有最大份额，这得益于强大的医疗保健基础设施和先进技术的早期采用。亚太地区作为重要贡献者，受到人口规模和医疗保健投资增加的推动。未来，亚太地区和南美预计将因医疗服务可及性的改善而实现最快增长。
North America holds the largest share of the point of care hematology diagnostics market, supported by strong healthcare infrastructure and early adoption of advanced technologies. Asia Pacific follows as a major contributor.
技术进步正在显著重塑即时血液学诊断市场。人工智能在诊断设备中的集成使得更快速和更准确的分析成为可能，支持更快的临床决策。紧凑和便携式分析仪使得直接在诊所和偏远环境中进行测试成为可能，而无需依赖集中实验室。
Technological progress is significantly reshaping the point of care hematology diagnostics market. The integration of artificial intelligence into diagnostic devices is enabling faster and more accurate analysis, supporting quicker clinical decisions.
数据来源：The Business Research Company (TBRC) |http://www.thebusinessresearchcompany.com
关于The Business Research Company
The Business Research Company (TBRC)是一家领先的市场情报公司，在企业、市场与消费者研究领域享有盛誉。我们已发布超过17,500份报告，覆盖27个行业与60多个地区。我们的研究基于1,500,000个数据集、广泛的二手研究以及对行业领袖的独家访谈。
我们通过市场进入研究包、竞争对手追踪包、供应商与经销商包等专项服务，提供持续及定制化研究支持。
https://www.thebusinessresearchcompany.com
